EAGLE PHARMACEUTICALS, INC. Quarterly Other Assets, Noncurrent in USD from Q3 2013 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Eagle Pharmaceuticals, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q3 2013 to Q2 2023.
  • Eagle Pharmaceuticals, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2023 was $33.4M, a 373% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $33.4M +$26.3M +373% Jun 30, 2023 10-Q/A 2023-08-09
Q1 2023 $33.5M +$26.1M +349% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $25.7M +$15.5M +150% Dec 31, 2022 10-Q/A 2023-08-09
Q3 2022 $26M +$11.4M +78.8% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $7.07M -$14.4M -67.1% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $7.46M -$20M -72.9% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $10.3M -$6.93M -40.3% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $14.5M +$962K +7.09% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $21.5M +$3.88M +22.1% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $27.5M +$12M +76.9% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $17.2M +$13.3M +340% Dec 31, 2020 10-K 2022-03-08
Q3 2020 $13.6M +$8.6M +173% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $17.6M +$14.4M +453% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $15.5M +$12M +336% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $3.91M +$3.21M +463% Dec 31, 2019 10-K 2021-03-05
Q3 2019 $4.98M +$4.27M +605% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $3.18M +$2.47M +350% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $3.57M +$3.46M +3263% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $694K +$570K +460% Dec 31, 2018 10-K 2020-03-02
Q3 2018 $706K +$582K +469% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $706K +$128K +22.1% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $106K -$512K -82.8% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $124K -$12K -8.82% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $124K +$30K +31.9% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $578K +$484K +515% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $618K +$524K +557% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 $136K -$7K -4.9% Dec 31, 2016 10-K 2018-02-26
Q3 2016 $94K -$17K -15.3% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $94K -$10K -9.62% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $94K +$49K +109% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $143K +$98K +218% Dec 31, 2015 10-K 2017-03-15
Q3 2015 $111K +$66K +147% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 $104K +$59K +131% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 $45K $0 0% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 $45K Dec 31, 2014 10-K 2016-02-29
Q3 2014 $45K -$1K -2.17% Sep 30, 2014 10-K 2016-02-29
Q2 2014 $45K Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $45K Mar 31, 2014 10-Q 2014-05-15
Q3 2013 $46K Sep 30, 2013 10-K 2014-12-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.